Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
5 Stocks Priced Under $10 That You Must Buy
By Tip Ranks
Apr 17, 2018 7:53 AM EDT
PRESS RELEASES
Bellicum Reports FDA Lifted Clinical Hold On BPX-601Â Phase 1/2 Clinical Trial
By GlobeNewswire
Jan 28, 2021 4:05 PM EST
PRESS RELEASES
Bellicum Enrolls First Patient In Phase 1/2 Clinical Trial for BPX-603
By GlobeNewswire
Dec 10, 2020 7:30 AM EST
PRESS RELEASES
Bellicum Reports Clinical Hold Placed On BPX-601 Phase 1/2 Clinical Trial
By GlobeNewswire
Dec 7, 2020 7:30 AM EST
PRESS RELEASES
Bellicum Pharmaceuticals Announces Closing Of $25.0 Million Underwritten Offering
By GlobeNewswire
Nov 3, 2020 8:25 PM EST
PRESS RELEASES
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
By GlobeNewswire
Oct 29, 2020 5:16 PM EDT
PRESS RELEASES
Bellicum Announces Interim BPX-601 Data And Corporate Restructuring
By GlobeNewswire
Oct 29, 2020 5:15 PM EDT
PRESS RELEASES
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Sep 30, 2020 4:06 PM EDT
PRESS RELEASES
Bellicum To Participate In Two Upcoming Virtual Conferences
By GlobeNewswire
Sep 28, 2020 7:30 AM EDT
PRESS RELEASES
Bellicum To Participate In Two Upcoming Virtual Investor Conferences
By GlobeNewswire
Sep 2, 2020 7:30 AM EDT
PRESS RELEASES
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Aug 31, 2020 4:07 PM EDT
STOCKS
5 Stocks Priced Under $10 That You Must Buy
By Tip Ranks
Apr 17, 2018 7:53 AM EDT
MERGERS AND ACQUISITIONS
Why 2018 will be better for biotech deals than 2017
By Armie Margaret Lee
Jan 25, 2018 7:15 PM EST
OPINION
Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI
By Michael Brown
Jan 22, 2018 7:23 PM EST
STOCKS
Immunotherapy stocks power higher on Celgene-Juno deal
By Armie Margaret Lee
Jan 22, 2018 12:03 PM EST
OPINION
Elliott Notches Win at Advisory Board, Monitors Progress with NRG - ICYMI
By Michael Brown
Aug 29, 2017 7:30 PM EDT
HEALTH
Kite Soars on Sale to Gilead - Biotech Movers
By Armie Margaret Lee
Aug 28, 2017 9:53 AM EDT
HEALTH
Biotech Movers: Ironwood Shares Jump On FDA Approval for Hyperuricemia Drug
By Armie Margaret Lee
Aug 21, 2017 9:33 AM EDT
STOCKS
Biotech Movers: Global Blood Shares Rise on PRIME Designation
By Armie Margaret Lee
Jun 28, 2017 9:29 AM EDT
STOCKS
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
By Roberto Pedone
Jun 23, 2017 12:14 PM EDT
HEALTH
Biotech Movers: Shire, Bellicum, Organovo
By Armie Margaret Lee
Jun 22, 2017 9:36 AM EDT
HEALTH
Biotech Movers: XBiotech, Atara, Bellicum
By Armie Margaret Lee
Apr 21, 2017 9:34 AM EDT
HEALTH
Biotech Movers: Sarepta, Bellicum, Novavax
By Armie Margaret Lee
Apr 5, 2017 9:23 AM EDT
STOCKS
5 Stocks Trending Close to Major Breakouts
By Roberto Pedone
Mar 17, 2017 1:49 PM EDT
STOCKS
Biotech movers: Shire rises on encouraging angioedema results
By William McConnell
Feb 23, 2017 9:20 AM EST
